血清miRNAs作为食管鳞癌新的生物标志物

doi:10.16288/j.yczz.14-441

遗传 ›› 2015, Vol. 37 ›› Issue (4): 315-320.doi: 10.16288/j.yczz.14-441

• 综述 • 下一篇

血清miRNAs作为食管鳞癌新的生物标志物

李迎迎¹,刘志广²,王丽¹,袁园园¹,刘平²,王林嵩¹

1. 河南师范大学生命科学学院,新乡 453007;
2. 河南省新乡市中心医院肿瘤科,新乡 453000

收稿日期:2014-12-15 出版日期:2015-04-20 发布日期:2015-03-12
通讯作者: 王林嵩,博士,教授,研究方向：生物化学与分子生物学。E-mail: wls@htu.cn E-mail:liyingly47@163.com
作者简介:李迎迎,在读硕士研究生,专业方向：生物化学与分子生物学。E-mail: liyingly47@163.com
基金资助:
新乡市重大科技攻关项目(编号：ZG13002)资助

Serum miRNAs as new biomarkers for esophageal squamous cell carcinoma

Yingying Li¹,Zhiguang Liu²,Li Wang¹,Yuanyuan Yuan¹,Ping Liu²,Linsong Wang¹

1. College of Life Sciences, Henan Normal University, Xinxiang 453007, China;
2. Surgical Oncology, Xinxiang Central Hospital, Xinxiang 453000, China

Received:2014-12-15 Online:2015-04-20 Published:2015-03-12

摘要/Abstract

摘要： 食管鳞癌是我国最常见的恶性肿瘤之一。由于缺乏有效的早期诊断方法,大多数食管鳞癌患者在确诊时已到中晚期并预后不良。MicroRNAs(miRNAs)是一类可通过抑制其特异性靶基因表达从而调控食管鳞癌发生发展的非编码内源性小RNA。相比于传统的生物标志物(例如mRNA和蛋白质),miRNAs更加稳定并易于筛选及精确地定量分析,从而成为理想的新一代癌症早期诊断和预后评估的生物标志物。近来的研究结果显示,食管鳞癌病人血清中的一些miRNAs表达水平的变化与病情诊断及预后的结果显著相关。文章综述了食管鳞癌病人血清中miRNAs的变化规律,讨论了检测这些miRNAs的表达水平变化作为一种新的方法应用于食管鳞癌的早期诊断和预后评估的可能性。值得注意的是,不同的血清miRNAs的检测方法所产生的结果是不完全一致的,文章还对这些差异产生的原因进行了讨论。

关键词: 血清, miRNA, 食管鳞癌

Abstract: Esophageal squamous cell carcinoma (ESCC) is one of the most common types of malignancies in China. Most ESCC patients are diagnosed at middle to late stages with poor prognosis due to the lack of an effective method for early diagnosis. MicroRNAs (miRNAs) are a family of endogenous small non-coding RNAs that can regulate ESCC development and progression by repressing their specific target genes’ expression. Compared to traditional biomarkers (e.g., mRNAs and proteins), miRNAs are more stable and can be readily screened and accurately quantitated and analyzed, making them ideal new-generation of biomarkers for early cancer detection and prognostic evaluation. Recent studies have shown that the changes of the expression levels of some serum miRNAs from ESCC patients significantly correlate with their diagnostic and prognostic outcome. In this review, we summarize the trend of the expression changes of miRNAs in ESCC patients’ serum and discuss the possibility of detecting these miRNAs’ expression changes as a novel method for ESCC early diagnosis and prognostic evaluation. Notably, the results of serum miRNAs from different detection methods are not completely consistent. Thus, we also discuss several possible reasons for such inconsistency.

Key words: serum, miRNA, esophageal squamous cell carcinoma

李迎迎,刘志广,王丽,袁园园,刘平,王林嵩. 血清miRNAs作为食管鳞癌新的生物标志物[J]. 遗传, 2015, 37(4): 315-320.

Yingying Li,Zhiguang Liu,Li Wang,Yuanyuan Yuan,Ping Liu,Linsong Wang. Serum miRNAs as new biomarkers for esophageal squamous cell carcinoma[J]. HEREDITAS(Beijing), 2015, 37(4): 315-320.

参考文献

[1] Fu WB, Pang LJ, Chen YZ, Yang L, Zhu JB, Wei YT. The microRNAs as prognostic biomarkers for survival in esophageal cancer: a meta-analysis. Scientific World J , 2014, 2014: 523979.
[2] Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. Ca Cancer J Clin , 2011, 61(2): 69-90.
[3] Hong L, Han Y, Zhang HW, Zhao QC, Wu KC, Fan DM. Prognosis-related microRNAs in esophageal cancer. Expert Opin Biol Ther , 2014, 14(4): 483-489.
[4] Zhou SL, Wang LD. Circulating microRNAs: novel biomarkers for esophageal cancer. World J Gastroenterol , 2010, 16(19): 2348-2354.
[5] Zhang C, Xue GL, Bi JW, Geng M, Chu HL, Guan YP, Wang J, Wang BC. Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma. Tumor Biol , 2014, 35(1): 73-80.
[6] Zhang CN, Wang C, Chen X, Yang CH, Li K, Wang JJ, Dai JC, Hu ZB, Zhou XJ, Chen LB, Zhang YN, Li YF, Qiu H, Xing JC, Liang ZC, Ren BH, Yang C, Zen K, Zhang CY. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem , 2010, 56(12): 1871-1879.
[7] Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, Nagata H, Kosuga T, Iitaka D, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Otsuji E. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer , 2011, 105(1): 104-111.
[8] Tanaka K, Yano M, Motoori M, Kishi K, Miyashiro I, Shingai T, Gotoh K, Noura S, Takahashi H, Ohue M, Yamada T, Ohigashi H, Yamamoto T, Yamasaki T, Doki Y, Ishikawa O. CEA-antigen and SCC-antigen mRNA expression in peripheral blood predict hematogenous recurrence after resection in patients with esophageal cancer. Ann Surg Oncol , 2010, 17(10): 2779-2786.
[9] 蔡晓波, 李庆, 郭俊明, 徐进, 季林丹. MicroRNA与食管癌的研究进展. 中国细胞生物学学报, 2013, 35(9): 1405-1411.
[10] Wu CH, Li MJ, Hu C, Duan HB. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma. Mol Biol Rep , 2014, 41(3): 1257-1266.
[11] Song YM, Li L, Ou YW, Gao ZB, Li EM, Li XC, Zhang WM, Wang JQ, Xu LY, Zhou Y, Ma XJ, Liu LY, Zhao ZT, Huang XL, Fan J, Dong LJ, Chen G, Ma LY, Yang J, Chen LY, He MH, Li M, Zhuang XH, Huang K, Qiu KL, Yin GL, Guo GW, Feng Q, Chen PS, Wu ZY, Wu JY, Ma L, Zhao JY, Luo LH, Fu M, Xu BN, Chen B, Li YR, Tong T, Wang MR, Liu ZH, Lin DX, Zhang XQ, Yang HM, Wang J, Zhan QM. Identification of genomic alterations in oesophageal squamous cell cancer. Nature , 2014, 509(7498): 91-95.
[12] Finnegan EF, Pasquinelli AE. MicroRNA biogenesis: regulating the regulators. Crit Rev Biochem Mol Biol , 2013, 48(1): 51-68.
[13] Yu H, Duan BS, Jiang L, Lin M, Sheng HH, Huang JX, Gao HJ. Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy. Am J Transl Res , 2013, 6(1): 71-77.
[14] Badal SS, Danesh FR. MicroRNAs and their applications in kidney diseases. Pediatr Nephrol , 2014, doi:10.1007/s00467-014-2867-7.
[15] Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature , 2005, 435(7043): 834-838.
[16] Ashby J, Flack K, Jimenez LA, Duan YK, Khatib AK, Somlo G, Wang SE, Cui X, Zhong W. Distribution profiling of circulating microRNAs in serum. Anal Chem , 2014, 86(18): 9343-9349.
[17] Chen X, Ba Y, Ma LJ, Cai X, Yin Y, Wang KH, Guo JG, Zhang YJ, Chen JN, Guo X, Li QB, Li XY, Wang WJ, Zhang Y, Wang J, Jiang XY, Xiang Y, Xu C, Zheng PP, Zhang JB, Li RQ, Zhang HJ, Shang XB, Gong T, Ning G, Wang J, Zen K, Zhang JF, Zhang CY. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res , 2008, 18(10): 997-1006.
[18] Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CSR, Harris AL. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol , 2008, 141(5): 672-675.
[19] Jarry J, Schadendorf D, Greenwood C, Spatz A, van Kempen LC. The validity of circulating microRNAs in oncology: five years of challenges and contradictions. Mol Oncol , 2014, 8(4): 819-829.
[20] Komatsu S, Ichikawa D, Takeshita H, Morimura R, Hirajima S, Tsujiura M, Kawaguchi T, Miyamae M, Nagata H, Konishi H, Shiozaki A, Otsuji E. Circulating miR-18a: a sensitive cancer screening biomarker in human cancer. In Vivo , 2014, 28(3): 293-297.
[21] Wu CY, Wang C, Guan XC, Liu YX, Li DM, Zhou XJ, Zhang YN, Chen X, Wang JJ, Zen K, Zhang CY, Zhang CN. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma. PLoS One , 2014, 9(3): e92292.
[22] Zou KH, O’Malley AJ, Mauri L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation , 2007, 115(5): 654-657.
[23] Hirajima S, Komatsu S, Ichikawa D, Takeshita H, Konishi H, Shiozaki A, Morimura R, Tsujiura M, Nagata H, Kawaguchi T, Arita T, Kubota T, Fujiwara H, Okamoto K, Otsuji E. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer , 2013, 108(9): 1822-1829.
[24] Komatsu S, Ichikawa D, Hirajima S, Kawaguchi T, Miyamae M, Okajima W, Ohashi T, Arita T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Yagi N, Otsuji E. Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma. Br J Cancer , 2014, 111(8): 1614-1624.
[25] Zhang TF, Wang QM, Zhao D, Cui YL, Cao BR, Guo LP, Lu SH. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin Sci , 2011, 121(10): 437-447.
[26] Sharma P, Saraya A, Gupta P, Sharma R. Decreased levels of circulating and tissue miR-107 in human esophageal cancer. Biomarkers , 2013, 18(4): 322-330.
[27] Liu R, Liao J, Yang M, Shi YJ, Peng Y, Wang Y, Pan EC, Guo W, Pu YP, Yin LH. Circulating miR-155 expression in plasma: a potential biomarker for early diagnosis of esophageal cancer in humans. J Toxicol Environ Health A , 2012, 75(18): 1154-1162.
[28] 张燕妮, 李艳芳, 王成, 管晓翠, 陈熹, 曾科, 张辰宇, 张春妮. 食管鳞状细胞癌患者血清全基因组microRNA测序和分析. 临床检验杂志, 2012, 30(9): 641-644.
[29] Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y, Ikeda N, Isozaki Y, Maruyama T, Akanuma N, Komatsu A, Jitsukawa M, Matsubara H. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer , 2013, 108(3): 644-652.
[30] Zhang TF, Zhao D, Wang QM, Yu XY, Cui YL, Guo LP, Lu SH. MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma. Mol Carcinog , 2013, 52(8): 581-590.
[31] Wang YY, Wang QX, Zhang N, Ma H, Gu YH, Tang HM, Xu ZG, Gao Y. Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis. Tumor Biol , 2014, 35(11): 11596-11604.
[32] Kurashige J, Kamohara H, Watanabe M, Tanaka Y, Kinoshita K, Saito S, Hiyoshi Y, Iwatsuki M, Baba Y, Baba H. Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma. J Surg Oncol , 2012, 106(2): 188-192.
[33] 彭学宏, 陈暖, 李克, 郑邦希. 食管癌外周血miRNA的研究. 中国校医, 2013, 27(5): 353-355.
[34] 曹波, 张红涛, 朱亚婷, 马媛媛. 新疆哈族食管癌血清microRNA初步筛查. 科技视界, 2014, (20): 62-63.
[35] 彭学宏, 陈暖, 李克, 郑邦希. 实时荧光定量PCR检测食管癌循环miRNA的研究. 中国实用医刊, 2014, 41(6): 1-2.
[36] Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods , 2010, 50(4): 298-301.
[37] Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, Reid G. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One , 2011, 6(9): e24145.
[38] Hunter MP, Ismail N, Zhang XL, Aguda BD, Lee EJ, Yu LB, Xiao T, Schafer J, Lee MLT, Schmittgen TD, Nana-Sinkam SP, Jarjoura D, Marsh CB. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One , 2008, 3(11): e3694.
[39] Tanaka Y, Kamohara H, Kinoshita K, Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M, Baba H. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer , 2013, 119(6): 1159-1167.
[40] Tanaka K, Miyata H, Yamasaki M, Sugimura K, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y. Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer. Ann Surg Oncol , 2013, 20(S3): 607-615.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

血清miRNAs作为食管鳞癌新的生物标志物

Serum miRNAs as new biomarkers for esophageal squamous cell carcinoma

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	饶琳, 孟飞龙, 房冉, 蔡晨依, 赵小立. MicroRNA调控耳蜗毛细胞发育的分子机制[J]. 遗传, 2019, 41(11): 994-1008.
[2]	夏蒙蒙,申雪沂,牛长敏,夏静,孙红亚,郑英. MicroRNA参与调控睾丸支持细胞的增殖与粘附功能[J]. 遗传, 2018, 40(9): 724-732.
[3]	刘海龙, 谌阳, 高杨, 周玲, 韩晓松, 赵长志, 杨高娟, 陈毅龙, 杨慧, 谢胜松. 靶向miRNA前体不同类型sgRNA的丰度及特异性评估[J]. 遗传, 2018, 40(7): 561-571.
[4]	肖娟, 王讯, 罗毅, 李晓开, 李学伟. 附睾小体功能蛋白及sRNA研究进展[J]. 遗传, 2018, 40(3): 197-206.
[5]	李新云, 付亮亮, 程会军, 赵书红. MicroRNA调控哺乳动物骨骼肌发育[J]. 遗传, 2017, 39(11): 1046-1053.
[6]	刘辰东, 杨露, 蒲红州, 杨琼, 黄文耀, 赵雪, 朱砺, 张顺华. 运动对骨骼肌基因表达的表观遗传调控作用[J]. 遗传, 2017, 39(10): 888-896.
[7]	魏俊,陆秀君,张晓林,梅梅,黄晓丽. MicroRNA在种子发育、休眠与萌发过程中的作用[J]. 遗传, 2017, 39(1): 14-21.
[8]	张轲, 冯光德, 张宝云, 向伟, 陈龙, 杨芳, 储明星, 王凭青. 表观遗传标记在猪分子育种中的研究与应用前景[J]. 遗传, 2016, 38(7): 634-643.
[9]	符梅, 徐克惠, 许文明. Dicer调节生殖功能的研究进展[J]. 遗传, 2016, 38(7): 612-622.
[10]	陈龙, 张宝云, 冯光德, 向伟, 马云霞, 陈航, 储明星, 王凭青. miRNA介导PGR信号通路在雌性生殖功能调节中的作用机制[J]. 遗传, 2016, 38(1): 40-51.
[11]	周学, 杜宜兰, 金萍, 马飞. 癌症相关microRNA与靶基因的生物信息学分析[J]. 遗传, 2015, 37(9): 855-864.
[12]	王冬, 李永君, 丁楠, 王均云, 杨琼, 杨雅冉, 李艳明, 方向东, 赵华. miRNA调控恶性黑色素瘤细胞上皮-间充质转化的分子网络及机制[J]. 遗传, 2015, 37(7): 673-682.
[13]	孙凌云, 李星逾, 孙志为. 原发性肝癌的表观遗传学及其治疗[J]. 遗传, 2015, 37(6): 517-527.
[14]	龚淑敏, 丁艳菲, 朱诚. miRNA在植物种子发育过程中的作用[J]. 遗传, 2015, 37(6): 554-560.
[15]	王春丽,郝佳洁,吴李飞,潘蓓青,徐昕,蔡岩,王明荣,贾雪梅. IGHMBP2过表达促进食管鳞癌细胞的侵袭和迁移[J]. 遗传, 2015, 37(4): 360-366.